TIME-DEPENDENT BLOCKADE OF NEUROGENIC PLASMA EXTRAVASATION IN DURA-MATER BY 5-HT1B/D AGONISTS AND ENDOPEPTIDASE 24.11

被引:33
|
作者
HUANG, ZH [1 ]
BYUN, B [1 ]
MATSUBARA, T [1 ]
MOSKOWITZ, MA [1 ]
机构
[1] HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,NEUROSURG & NEUROL SERV,STROKE RES LAB,BOSTON,MA 02114
关键词
CP-93,129; SUMATRIPTAN; ENDOPEPTIDASE; 24.11; 5-HT1B RECEPTORS; 5-HT1D RECEPTORS; MIGRAINE; DURA MATER; NEUROGENIC INFLAMMATION;
D O I
10.1111/j.1476-5381.1993.tb12805.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The delayed effects of stimulating the trigeminal ganglion unilaterally in rats and guinea-pigs were assessed by measuring the leakage of radiolabelled albumin from blood into the dura mater at intervals for up to 120 min after a 5 min stimulation period (5 Hz, 0.6 mA, 5 ms). 2 [I-125]-albumin (50 muCi kg-1) was injected i.v. as a tracer 0, 20, 50, 80 or 110 min after stimulation and the animals were killed 10 min later. Extravasation of plasma protein developed for up to 90 min poststimulation. 3 To examine the mechanism underlying delayed plasma protein extravasation, CP-93,129 (5-HT1B receptor agonist, 460 nmol kg-1), sumatriptan (5-HT1B/D receptor agonist, 24 nmol kg-1), or neutral endopeptidase 24.11 (1 nmol kg-1) were administered 45 or 75 min after trigeminal stimulation and 5 min before radiolabelled albumin. The extravasation response was reduced at 45 min. CP-23,129 also blocked extravasation when injected 25 min after capsaicin administration (1 mumol kg-1). 4 If the tracer was injected 5 min prior to electrical trigeminal stimulation, endopeptidase 24.11 (1 nmol kg-1) given 10 min before stimulation blocked the leakage (as reported previously for CP-93,129 or sumatriptan). All three compounds blocked the leakage when administered 30 min (but not 60 min) poststimulation in this paradigm. 5 The data support the previously made contention that neuropeptide release from sensory fibres mediates the plasma extravasation response following trigeminal ganglion stimulation, and that release and plasma leakage continue many minutes beyond the stimulation period. Hence, drugs that inhibit neuropeptide release (CP-93,129, sumatriptan), or enhance breakdown of neuropeptide mediators (endopeptidase 24.11) block the delayed extravasation response. Extravasation developing later than 45 min poststimulation was not neurogenically mediated.
引用
收藏
页码:331 / 335
页数:5
相关论文
共 50 条
  • [1] FURTHER CHARACTERIZATION OF THE PUTATIVE 5-HT RECEPTOR WHICH MEDIATES BLOCKADE OF NEUROGENIC PLASMA EXTRAVASATION IN RAT DURA-MATER
    BUZZI, MG
    MOSKOWITZ, MA
    PEROUTKA, SJ
    BYUN, B
    BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (02) : 1421 - 1428
  • [2] CP-93,129, A POTENT AND SELECTIVE 5-HT1B RECEPTOR AGONIST BLOCKS NEUROGENIC PLASMA EXTRAVASATION WITHIN RAT BUT NOT GUINEA-PIG DURA-MATER
    MATSUBARA, T
    MOSKOWITZ, MA
    BYUN, B
    BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (01) : 3 - 4
  • [3] Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats
    Shepherd, SL
    Williamson, DJ
    Beer, MS
    Hill, RG
    Hargreaves, RJ
    NEUROPHARMACOLOGY, 1997, 36 (4-5) : 525 - 533
  • [4] Localization of 5-HT1B/1D receptors in the trigeminal ganglion and dura mater
    Edvinsson, Jacob
    Haanes, Kristian A.
    Warfvinge, Karin N.
    Edvinsson, Lars
    CEPHALALGIA, 2019, 39 : 153 - 153
  • [5] THE NONPEPTIDE NEUROKININ(1)-RECEPTOR ANTAGONIST, RP-67580, BLOCKS NEUROGENIC PLASMA EXTRAVASATION IN THE DURA-MATER OF RATS
    SHEPHEARD, SL
    WILLIAMSON, DJ
    HILL, RG
    HARGREAVES, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 108 (01) : 11 - 12
  • [6] INVESTIGATION OF THE ROLE OF TACHYKININ NK1, NK2 RECEPTORS AND CGRP RECEPTORS IN NEUROGENIC PLASMA-PROTEIN EXTRAVASATION IN DURA-MATER
    OSHAUGHNESSY, CT
    CONNER, HE
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1994, 263 (1-2) : 193 - 198
  • [7] BLOCKADE BY ORAL OR PARENTERAL RPR-100893 (A NONPEPTIDE NK1 RECEPTOR ANTAGONIST) OF NEUROGENIC PLASMA-PROTEIN EXTRAVASATION WITHIN GUINEA-PIG DURA-MATER AND CONJUNCTIVA
    LEE, WS
    MOUSSAOUI, SM
    MOSKOWITZ, MA
    BRITISH JOURNAL OF PHARMACOLOGY, 1994, 112 (03) : 920 - 924
  • [8] Differentiating the efficacy of 5-HT1B/1D agonists
    Sheftell, FD
    Fox, AW
    Weeks, RE
    Tepper, SJ
    HEADACHE, 2001, 41 (03): : 257 - 263
  • [9] Trigeminal neurones that receive non-nociceptive vibrissal input in the anaesthetized rat: effects of convergent nociceptive input from the dura-mater and of a 5-HT1B/1D agonist.
    Cumberbatch, MJ
    Mason, GS
    Hill, RG
    Hargreaves, RJ
    JOURNAL OF PHYSIOLOGY-LONDON, 1997, 504P : P103 - P104
  • [10] Comparative tolerability of oral 5-HT1B/1D agonists
    Fox, AW
    HEADACHE, 2000, 40 (07): : 521 - 527